Zahra HALVAEI, Hiva TEHRANI, Kambiz SOLTANINEJAD, Mohammad ABDOLLAHI, Shahin SHADNIA

Vitamin E as a novel therapy in the treatment of acute aluminum phosphide poisoning

Background/aim: Aluminum phosphide (AlP) is commonly used as a fumigant in developing countries. Induction of oxidative stress is one of the most important mechanisms of its toxicity. In this regard, and considering that there is no specific antidote for its treatment, the aim of this study was to evaluate the effect of vitamin E in the treatment of acute AlP poisoning. Materials and methods: This was a clinical trial on acute AlP poisoned patients. All patients received supportive treatment. In addition, the treatment group received vitamin E (400 mg/BD/IM). Level of malondialdehyde (MDA) and total antioxidant capacity of plasma were measured. Results: There was no significant difference between the treatment and control groups with regard to demographic, clinical, or paraclinical data or Simplified Acute Physiology Score II (SAPSII) on admission. Systolic blood pressure significantly increased during the first 24 h in the treatment group (P < 0.05). The plasma MDA level significantly decreased in the treatment group (P < 0.05). Vitamin E administration decreased the necessity (30% vs. 62%, P < 0.05) and duration of intubation and mechanical ventilation (P < 0.05). It significantly reduced the mortality rate in the treatment group compared to the control group (15% vs. 50%, respectively, P < 0.05). Conclusion: Vitamin E along with supportive treatment could have a therapeutic effect in acute AlP poisoning.

PDF

___

1. Moghadamnia AA. An update on toxicology of aluminum phosphide. DARU 2012; 20: 25. doi:10.1186/2008-2231-20-25.
2. Sharma AD, Gupta V, Kaushik JS, Mittal K. Aluminum phosphide (Celphos) poisoning in children: a 5-year experience in a tertiary care hospital from northern India. Indian J Crit Care Med 2014; 18: 33-36.
3. Anand R, Binukumar BK, Gill KD. Aluminum phosphide poisoning: an unsolved riddle. J Appl Toxicol 2011; 31: 499- 505.
4. Shadnia S, Sasanian G, Allami P, Hosseini A, Ranjbar A, Amini-shirazi N, Abdollahi M. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: opportunities for prevention. Hum Exp Toxicol 2009; 28: 209-213.
5. Mehrpour O, Singh S. Rice tablet poisoning: a major concern in Iranian population. Hum Exp Toxicol 2010; 29: 701-702.
6. Soltaninejad K, Nelson LS, Bahreini SA, Shadnia S. Fatal aluminum phosphide poisoning in Tehran-Iran from 2007 to 2010. Indian J Med Sci 2012; 66: 66-70.
7. Shadnia S, Mehrpour O, Soltaninejad K. A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome. Indian J Med Sci 2010; 64: 532- 539.
8. Bumbrah GS, Krishan K, Kanchan T, Sharma M, Sodhi GS. Phosphide poisoning: a review of literature. Forensic Sci Int 2012; 214: 1-6. doi:10.1016/j.forsciint. 2011.06.018.
9. Proudfoot AT. Aluminium and zinc phosphide poisoning. Clin Toxicol (Phila) 2009; 47: 89-100.
10. Hsu CH, Chi BC, Casida JE. Melatonin reduces phosphineinduced lipid and DNA oxidation in vitro and in vivo in rat brain. J Pineal Res 2002; 32: 53-58.
11. Hsu CH, Chi BC, Liu MY, Li JH, Chen CJ, Chen RY. Phosphineinduced oxidative damage in rats: role of glutathione. Toxicology 2002; 179: 1-8.
12. Tehrani H, Halvaie Z, Shadnia S, Soltaninejad K, Abdollahi M. Protective effects of N-acetylcysteine on aluminum phosphideinduced oxidative stress in acute human poisoning. Clin Toxicol (Phila) 2013; 51: 23-28.
13. Kariman H, Heydari K, Fakhri M, Shahrami A, Arhami Dolatabadi A, Mohammadi HA, Gharibi M. Aluminium phosphide poisoning and oxidative stress: serum biomarker assessment. J Med Toxicol 2012; 8: 281-284.
14. Anand R, Sharma DR, Verma D, Bhalla A, Gill KD, Singh S. Mitochondrial electron transport chain complexes, catalase and markers of oxidative stress in platelets of patients with severe aluminum phosphide poisoning. Hum Exp Toxicol 2013; 32: 807-816.
15. Anand R, Kumari P, Kaushal A, Bal A, Wani WY, Sunkaria A, Dua R, Singh S, Bhalla A, Gill KD. Effect of acute aluminum phosphide exposure on rats - a biochemical and histological correlation. Toxicol Lett 2012; 215: 62-69.
16. Singh M, Sandhir R, Kiran R. Effects on antioxidant status of liver following atrazine exposure and its attenuation by vitamin E. Exp Toxicol Pathol 2011; 63: 269-276.
17. Singh M, Sandhir R, Kiran R. Oxidative stress induced by atrazine in rat erythrocytes: mitigating effect of vitamin E. Toxicol Mech Methods 2010; 20: 119-126.
18. Shadnia S, Dasgar M, Taghikhani S, Mohammadirad A, Khorasani R, Abdollahi M. Protective effects of α-tocopherol and N-acetyl-cysteine on diazinon-induced oxidative stress and acetylcholinesterase inhibition in rats. Toxicol Mech Methods 2007; 17: 109-115.
19. Satih K. Serum lipid peroxide in cerebrovascular disorders determined by a new calorimetric method. Clin Chim Acta 1978; 90: 37-43.
20. Benzie IE, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 1996; 239: 70-76.
21. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet 1974; 2: 81-84.
22. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
23. Wiser J, Alexis NE, Jiang Q, Wu W, Robinette C, Roubey R, Peden DB. In vivo gamma-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects. Free Radic Biol Med 2008; 45: 40-49.
24. Soltaninejad K, Abdollahi M. Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review. Med Sci Monit 2009; 15: RA75-90.
25. Ozden S, Catalgol B, Gezginci-Oktayoglu S, Arda-Pirincci P, Bolkent S, Alpertunga B. Methiocarb-induced oxidative damage following subacute exposure and the protective effects of vitamin E and taurine in rats. Food Chem Toxicol 2009; 47: 1676-1684.
26. Pryor W. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141-164.
27. Iannitti T, Palmieri B. Antioxidant therapy effectiveness: an up to date. Eur Rev Med Pharmacol Sci 2009; 13: 245-278.
28. Mehrpour O, Alfred S, Shadnia S, Keyler DE, Soltaninejad K, Chalaki N, Sedaghat M. Hyperglycemia in acute aluminum phosphide poisoning as a potential prognostic factor. Hum Exp Toxicol 2008; 27: 591-595.
29. Hajouji Idrissi M, Oualili L, Abidi K, Abouqal R, Kerkeb O, Zeggwagh AA. Severity factors of aluminum phosphide poisoning (Phostoxin). Ann Fr Anesth Reanim 2006; 25: 382- 385.